Evidence map›Paper›PMID 31781192›Full record

ArticleGastroenterology research and practice2019

The Feasibility and Histological Diagnostic Accuracy of Novel Menghini Needle (EUS Sonopsy CY™) for Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsy of Solid Pancreatic Masses: A Prospective Crossover Study Comparing Standard Biopsy Needles.

Ryo Igarashi, Atsushi Irisawa, Manoop S Bhutani, Irina M Cazacu, Goro Shibukawa, Ai Sato, Akane Yamabe, Takumi Maki, Yoshitsugu Yoshida, Shogo Yamamoto and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Gastroenterology research and practice, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Ryo IgarashiDepartment of Gastroenterology, Aizu Medical Center, Fukushima Medical University, Fukushima, Japan.
Atsushi IrisawaDepartment of Gastroenterology, Aizu Medical Center, Fukushima Medical University, Fukushima, Japan.ORCID https://orcid.org/0000-0002-2271-2717
Manoop S BhutaniDepartment of Gastroenterology, Hepatology and Nutrition, Unit 1466, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA.
Irina M CazacuDepartment of Gastroenterology, Hepatology and Nutrition, Unit 1466, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA.
Goro ShibukawaDepartment of Gastroenterology, Aizu Medical Center, Fukushima Medical University, Fukushima, Japan.
Ai SatoDepartment of Gastroenterology, Aizu Medical Center, Fukushima Medical University, Fukushima, Japan.
Akane YamabeDepartment of Gastroenterology, Aizu Medical Center, Fukushima Medical University, Fukushima, Japan.ORCID https://orcid.org/0000-0002-5413-9636
Takumi MakiDepartment of Gastroenterology, Aizu Medical Center, Fukushima Medical University, Fukushima, Japan.
Yoshitsugu YoshidaDepartment of Gastroenterology, Aizu Medical Center, Fukushima Medical University, Fukushima, Japan.
Shogo YamamotoDepartment of Gastroenterology, Aizu Medical Center, Fukushima Medical University, Fukushima, Japan.
Tsunehiko IkedaDepartment of Gastroenterology, Aizu Medical Center, Fukushima Medical University, Fukushima, Japan.
Hiroshi HojoDepartment of Pathology, Aizu Medical Center, Fukushima Medical University, Fukushima, Japan.
Fukushima Medical University · JPThe University of Texas MD Anderson Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesRecently, a 21G Menghini-type needle for EUS-guided fine-needle aspiration biopsy (EUS-FNAB) has been developed. The stylet of the EUS Sonopsy CY™ remains inside the needle during aspiration. Therefore, it is expected to obtain higher-quality histological core specimens without crushing the material or blood contamination. The aim of this study is to evaluate the feasibility and diagnostic accuracy of EUS-FNAB of solid pancreatic masses with this new biopsy needle.

methodsA total of 30 patients with solid pancreatic masses who underwent EUS-FNAB with two different types of needles, EUS Sonopsy™ and ProCore™, were included in a prospective, randomized, controlled, crossover study. All the pancreatic masses were punctured with the two needles and were randomized regarding the order of the needle to be used. The primary outcome was to compare the diagnostic accuracy and the rates of tissue acquisition of the two needles.

resultsThe tissue acquisition rate was not significantly different between the EUS Sonopsy CY™ needle and the ProCore™ needle (78.6% vs. 82.1%,

conclusionsEUS Sonopsy CY™ is a reliable device for EUS-FNAB of solid pancreatic masses.

Identifiers

PMID31781192
PMCPMC6855019
OpenAlexW2981499795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.